Phreesia, Inc. (NYSE:PHR) Insider Janet Gunzburg Sells 912 Shares

Phreesia, Inc. (NYSE:PHR) insider Janet Gunzburg sold 912 shares of the firm’s stock in a transaction on Thursday, April 18th. The stock was sold at an average price of $22.85, for a total value of $20,839.20. Following the completion of the transaction, the insider now owns 35,220 shares in the company, valued at approximately $804,777. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Janet Gunzburg also recently made the following trade(s):

• On Wednesday, April 10th, Janet Gunzburg sold 2,768 shares of Phreesia stock. The stock was sold at an average price of $23.10, for a total value of $63,940.80.
• On Monday, April 8th, Janet Gunzburg sold 1,709 shares of Phreesia stock. The stock was sold at an average price of $22.62, for a total value of $38,657.58.
• On Tuesday, March 19th, Janet Gunzburg sold 2,817 shares of Phreesia stock. The stock was sold at an average price of $23.27, for a total value of $65,551.59.
• On Friday, February 9th, Janet Gunzburg sold 480 shares of Phreesia stock. The shares were sold at an average price of $28.00, for a total value of $13,440.00.
• On Thursday, February 1st, Janet Gunzburg sold 328 shares of Phreesia stock. The shares were sold at an average price of $25.99, for a total value of $8,524.72.

Phreesia Stock Down 4.2 %

Shares of NYSE PHR opened at $21.67 on Friday. The business’s fifty day moving average price is $24.28 and its 200-day moving average price is $21.28. Phreesia, Inc. has a one year low of $12.05 and a one year high of $34.98. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.78 and a quick ratio of 1.78. The stock has a market capitalization of $1.22 billion, a PE ratio of -8.60 and a beta of 0.92.

Phreesia (NYSE:PHR) last issued its earnings results on Thursday, March 14th. The company reported ($0.56) earnings per share for the quarter, beating the consensus estimate of ($0.58) by $0.02. The company had revenue of $95.00 million during the quarter, compared to analysts’ expectations of $93.52 million. Phreesia had a negative return on equity of 53.33% and a negative net margin of 38.42%. Phreesia’s quarterly revenue was up 24.0% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.72) EPS. On average, equities research analysts anticipate that Phreesia, Inc. will post -1.48 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently commented on PHR shares. DA Davidson reissued a “neutral” rating and set a $32.00 price target on shares of Phreesia in a research note on Friday, March 15th. Canaccord Genuity Group lifted their target price on Phreesia from $36.00 to $37.00 and gave the stock a “buy” rating in a report on Friday, March 15th. Barclays initiated coverage on Phreesia in a report on Wednesday, January 3rd. They set an “overweight” rating and a $29.00 price objective for the company. Truist Financial initiated coverage on Phreesia in a report on Monday, February 26th. They set a “buy” rating and a $35.00 price objective for the company. Finally, Stephens reaffirmed an “overweight” rating and set a $28.00 target price on shares of Phreesia in a research report on Friday, March 22nd. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $31.62.

Institutional Investors Weigh In On Phreesia

Several institutional investors and hedge funds have recently bought and sold shares of PHR. Brown Advisory Inc. lifted its holdings in Phreesia by 22.2% in the 4th quarter. Brown Advisory Inc. now owns 3,950,356 shares of the company’s stock worth $91,451,000 after buying an additional 716,374 shares during the period. FMR LLC lifted its holdings in Phreesia by 8.6% in the 3rd quarter. FMR LLC now owns 7,856,551 shares of the company’s stock worth $146,760,000 after buying an additional 624,456 shares during the period. Rock Springs Capital Management LP raised its position in shares of Phreesia by 36.1% in the 3rd quarter. Rock Springs Capital Management LP now owns 1,776,391 shares of the company’s stock worth $33,183,000 after acquiring an additional 471,391 shares in the last quarter. Norges Bank purchased a new position in shares of Phreesia in the 4th quarter valued at approximately $8,199,000. Finally, BlackRock Inc. lifted its stake in shares of Phreesia by 5.8% in the 1st quarter. BlackRock Inc. now owns 6,359,641 shares of the company’s stock valued at $167,640,000 after purchasing an additional 349,301 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.